“…The significantly lower plasma binding of both iotroxamide and ioglycamide in the presence of jaundice probably reflects the fact that other substances in the patient's blood are competing for albumin binding sites. Bilirubin has been shown to displace a number of drugs from their binding sites (Coutinho, Luceck, Cheripho & Kuntzman, 1973;Odell, 1959;Olsen, Bennett & Porter, 1975;Williams, Blaschke, Meffin, Melman & Rowland, 1977), as can free fatty acids (Spector & Santor, 1973;Fredholme, Raine & Persson, 1975), and possibly other compounds known to be raised in the presence of jaundice (Williams et al, 1977;Perez-Mateo & Everill, 1977). The renal excretion of iotroxamide, like iodipamide and other cholangiographic agents, is likely to be predominantly by glomerular filtration (Fischer, 1965;Loeb, Berk, Feld & Wheeler, 1975).…”